Invention Grant
- Patent Title: Functionalized heterocycles as antiviral agents
-
Application No.: US17517740Application Date: 2021-11-03
-
Publication No.: US11891393B2Publication Date: 2024-02-06
- Inventor: Joseph Panarese , Dexter Davis , Samuel Bartlett , Katherine Chong , Nathaniel Kenton , Yat Sun Or
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07D471/14
- IPC: C07D471/14 ; A61K31/4985 ; A61K45/06
Abstract:
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, thereof:
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
Public/Granted literature
- US20230075366A1 FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS Public/Granted day:2023-03-09
Information query
